
Journal of Medicinal Chemistry p. 709 - 714 (1982)
Update date:2022-08-05
Topics:
Leclerc, Gerard
Decker, Nicole
Schwartz, Jean
A series of 24 cyclohexylaralkylamine derivatives related to perhexilene has been synthesized and screened for cardiovascular activity.All the compounds contained an exocyclic amine which was substituted either by an alkyl, cycloalkyl, or aralkyl group.In the hope of further reducing toxicity, the synthesis of p-tolyl- and p-hydroxyphenyl derivatives 23 and 24 was undertaken.The effect of separating the cyclohexylamine moiety with respect to the aromatic nucleus has been systematically examined.The pharmacological investigations were directed to a search for compounds having an activity better than perhexiline according to the following order of criteria: (1) α-adrenolytic activity; (2) increase of coronary blood flow; (3) calcium antagonism.Several compounds were more potent and exhibited lower toxicity than perhexiline.Further detailed pharmacological investigations (tension time index and decreased cardiac work) have led to the selection of N,2-dicyclohexyl-2-phenethylamine (3) for clinical trials, which are now under way.
View MoreAnhui Eapearl Chemical Co., Ltd.
Contact:86-562-5858458
Address:358 South Huaihe Road
LinHai Cina Chemical Co., LTD.
Contact:0576-85580989
Address:Pharma-chem zone,Duqiao,Linhai,Zhejiang,China
RongCheng Tianyu Technology Co.,Ltd.
Contact:86-631-7519595
Address:220Ping Donghai Road RongChengCity,ShangDong Province China
Shenzhen Sungening Medicine Co., Ltd
Contact:+86-871-65110906
Address:Room702, Building 2, 365 Dianchi Road, Kunming, Yunnan Province, P.R. China
Contact:86 21 3772 9386
Address:Rm.1803,Starry Bldg.1,1505 Meijiabang Road,Shanghai 201620 China
Doi:10.1007/BF00799022
(1982)Doi:10.1021/ja00376a017
(1982)Doi:10.1055/s-2006-948182
(2006)Doi:10.1016/j.tetasy.2004.08.037
(2004)Doi:10.1021/ja0484597
(2004)Doi:10.1039/P29880001045
(1988)